BridgeMD
New treatment option for Myopia
Official title Mobility Performance in Daily Activities Among Children Wearing Spectacle Lenses
ClinicalTrials.gov ID: NCT07229352
What this study is testing
- What it's testing
- The aim of this study is evaluate and compare the mobility performance of children in daily activities while wearing single vision spectacle lenses (control) versus myopia control spectacle lenses (test).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12. Healthy volunteers may be eligible.
You may be able to join if
- A participant is eligible for inclusion in the study if they meet the following criteria:
- Are between the ages of 6 and 12 years of age (inclusive) at the time of informed consent/assent.
- Can achieve a corrected visual acuity of 20/20 best-corrected (or equivalent logMAR).
- Have undergone a self-reported oculo-visual examination within the past two years.
- Have no active ocular disease.
You likely can't join if
- A participant will be excluded from the study if they meet any of the following conditions:
- Have any systemic disease that affects ocular health.
- Are currently using or have used, within the past 7 days, any systemic or topical medications that may impact ocular health.
- Are currently using or have used any topical ophthalmic agents with anti-muscarinic properties within 7 days prior to enrollment or at any point...
- Have used any oral agents with anti-muscarinic properties for a chronic period (2 months or more) or short-term (within 7 days prior to enrollment)...
- Have known developmental delays.
See the full eligibility criteria
- A participant is eligible for inclusion in the study if they meet the following criteria:
- Are between the ages of 6 and 12 years of age (inclusive) at the time of informed consent/assent.
- Can achieve a corrected visual acuity of 20/20 best-corrected (or equivalent logMAR).
- Have undergone a self-reported oculo-visual examination within the past two years.
- Have no active ocular disease.
- Are willing and able to adhere to instructions, study procedures, and maintain the appointment schedule.
- Have not previously worn or participated in myopia control contact lenses for more than one month and are not currently undergoing any form of myopia control treatment.
- The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.
- A participant will be excluded from the study if they meet any of the following conditions:
- Have any systemic disease that affects ocular health.
- Are currently using or have used, within the past 7 days, any systemic or topical medications that may impact ocular health.
- Are currently using or have used any topical ophthalmic agents with anti-muscarinic properties within 7 days prior to enrollment or at any point during the study. This includes, but is not limited to, atropine...
- Have used any oral agents with anti-muscarinic properties for a chronic period (2 months or more) or short-term (within 7 days prior to enrollment). This includes, but is not limited to, gastrointestinal anti-spasmodic...
- Have known developmental delays.
- Have participated in another clinical study in the last 7 days
The study team makes the final eligibility decision.
Where it's taking place
- Glendale, Arizona, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Glendale, Arizona, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.